Cargando…

Comparative Diagnostic Evaluation with Contrast-Enhanced Ultrasound, Computed Tomography and Magnetic Resonance Imaging in Patients with Pancreatic Cystic Neoplasms

PURPOSE: The purpose of our study was to evaluate the role of contrast-enhanced ultrasound (CEUS) with magnetic resonance imaging (MRI) and computed tomography (CT) in the pathological diagnosis of pancreatic cystic neoplasms (PCNs). METHODS: A total of 90 patients (66 women, 24 men) aged 18–71 year...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ya, Yang, Shuo, Qi, Erpeng, Liu, Fangyi, Zhou, Fubo, Lu, Yuhan, Liang, Ping, Ye, Huiyi, Yu, Xiaoling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196192/
https://www.ncbi.nlm.nih.gov/pubmed/32425602
http://dx.doi.org/10.2147/CMAR.S246564
_version_ 1783528673899446272
author Sun, Ya
Yang, Shuo
Qi, Erpeng
Liu, Fangyi
Zhou, Fubo
Lu, Yuhan
Liang, Ping
Ye, Huiyi
Yu, Xiaoling
author_facet Sun, Ya
Yang, Shuo
Qi, Erpeng
Liu, Fangyi
Zhou, Fubo
Lu, Yuhan
Liang, Ping
Ye, Huiyi
Yu, Xiaoling
author_sort Sun, Ya
collection PubMed
description PURPOSE: The purpose of our study was to evaluate the role of contrast-enhanced ultrasound (CEUS) with magnetic resonance imaging (MRI) and computed tomography (CT) in the pathological diagnosis of pancreatic cystic neoplasms (PCNs). METHODS: A total of 90 patients (66 women, 24 men) aged 18–71 years were studied prospectively. CEUS was performed in all patients, whereas MRI was performed in 85 patients and CT in 69 patients. We analyzed the sensitivity and accuracy of these three imaging modalities to diagnose the PCNs. Neoplasm size, location, shape, intralesional mural nodules, septa and duct dilatation were also assessed by different radiologists. RESULTS: There were no significant differences in sensitivity for discriminating PCNs from pancreatic cystic lesions between CEUS and MRI (p=0.614) or between CEUS and CT (p=0.479). The diagnostic accuracy of CEUS for classifying PCNs was 64.4% (58/90), which was higher than that of CT (53.6%, 37/69, P=0.017), and lower than that of MRI (70.6%, 60/85, p=0.791). Regarding tumor size for lesions larger than 3 cm, CEUS was superior to CT in differentiating the specific type of PCN (p=0.041), and CEUS had the same value as MRI (p=0.774). Furthermore, CEUS is valuable for precisely characterizing internal structures, for instance, septa (p=0.003, compared with CT; p=0.443, compared with MRI) and nodules (p= 0.018, compared with CT; p=0.033, compared with MRI). The number of septa (p=0.033) and cyst morphology (p=0.016) were meaningful indicators in differentiating serous and mucinous adenoma. There was no significant difference in evaluating size and detecting duct dilatation among the three imaging methods. CONCLUSION: CEUS compares favorably with MRI in displaying the inner structure of PCNs and offers advantages over CT. CEUS can contribute in an important way to the diagnosis of pancreatic cystic neoplasms.
format Online
Article
Text
id pubmed-7196192
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-71961922020-05-18 Comparative Diagnostic Evaluation with Contrast-Enhanced Ultrasound, Computed Tomography and Magnetic Resonance Imaging in Patients with Pancreatic Cystic Neoplasms Sun, Ya Yang, Shuo Qi, Erpeng Liu, Fangyi Zhou, Fubo Lu, Yuhan Liang, Ping Ye, Huiyi Yu, Xiaoling Cancer Manag Res Original Research PURPOSE: The purpose of our study was to evaluate the role of contrast-enhanced ultrasound (CEUS) with magnetic resonance imaging (MRI) and computed tomography (CT) in the pathological diagnosis of pancreatic cystic neoplasms (PCNs). METHODS: A total of 90 patients (66 women, 24 men) aged 18–71 years were studied prospectively. CEUS was performed in all patients, whereas MRI was performed in 85 patients and CT in 69 patients. We analyzed the sensitivity and accuracy of these three imaging modalities to diagnose the PCNs. Neoplasm size, location, shape, intralesional mural nodules, septa and duct dilatation were also assessed by different radiologists. RESULTS: There were no significant differences in sensitivity for discriminating PCNs from pancreatic cystic lesions between CEUS and MRI (p=0.614) or between CEUS and CT (p=0.479). The diagnostic accuracy of CEUS for classifying PCNs was 64.4% (58/90), which was higher than that of CT (53.6%, 37/69, P=0.017), and lower than that of MRI (70.6%, 60/85, p=0.791). Regarding tumor size for lesions larger than 3 cm, CEUS was superior to CT in differentiating the specific type of PCN (p=0.041), and CEUS had the same value as MRI (p=0.774). Furthermore, CEUS is valuable for precisely characterizing internal structures, for instance, septa (p=0.003, compared with CT; p=0.443, compared with MRI) and nodules (p= 0.018, compared with CT; p=0.033, compared with MRI). The number of septa (p=0.033) and cyst morphology (p=0.016) were meaningful indicators in differentiating serous and mucinous adenoma. There was no significant difference in evaluating size and detecting duct dilatation among the three imaging methods. CONCLUSION: CEUS compares favorably with MRI in displaying the inner structure of PCNs and offers advantages over CT. CEUS can contribute in an important way to the diagnosis of pancreatic cystic neoplasms. Dove 2020-04-28 /pmc/articles/PMC7196192/ /pubmed/32425602 http://dx.doi.org/10.2147/CMAR.S246564 Text en © 2020 Sun et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Sun, Ya
Yang, Shuo
Qi, Erpeng
Liu, Fangyi
Zhou, Fubo
Lu, Yuhan
Liang, Ping
Ye, Huiyi
Yu, Xiaoling
Comparative Diagnostic Evaluation with Contrast-Enhanced Ultrasound, Computed Tomography and Magnetic Resonance Imaging in Patients with Pancreatic Cystic Neoplasms
title Comparative Diagnostic Evaluation with Contrast-Enhanced Ultrasound, Computed Tomography and Magnetic Resonance Imaging in Patients with Pancreatic Cystic Neoplasms
title_full Comparative Diagnostic Evaluation with Contrast-Enhanced Ultrasound, Computed Tomography and Magnetic Resonance Imaging in Patients with Pancreatic Cystic Neoplasms
title_fullStr Comparative Diagnostic Evaluation with Contrast-Enhanced Ultrasound, Computed Tomography and Magnetic Resonance Imaging in Patients with Pancreatic Cystic Neoplasms
title_full_unstemmed Comparative Diagnostic Evaluation with Contrast-Enhanced Ultrasound, Computed Tomography and Magnetic Resonance Imaging in Patients with Pancreatic Cystic Neoplasms
title_short Comparative Diagnostic Evaluation with Contrast-Enhanced Ultrasound, Computed Tomography and Magnetic Resonance Imaging in Patients with Pancreatic Cystic Neoplasms
title_sort comparative diagnostic evaluation with contrast-enhanced ultrasound, computed tomography and magnetic resonance imaging in patients with pancreatic cystic neoplasms
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196192/
https://www.ncbi.nlm.nih.gov/pubmed/32425602
http://dx.doi.org/10.2147/CMAR.S246564
work_keys_str_mv AT sunya comparativediagnosticevaluationwithcontrastenhancedultrasoundcomputedtomographyandmagneticresonanceimaginginpatientswithpancreaticcysticneoplasms
AT yangshuo comparativediagnosticevaluationwithcontrastenhancedultrasoundcomputedtomographyandmagneticresonanceimaginginpatientswithpancreaticcysticneoplasms
AT qierpeng comparativediagnosticevaluationwithcontrastenhancedultrasoundcomputedtomographyandmagneticresonanceimaginginpatientswithpancreaticcysticneoplasms
AT liufangyi comparativediagnosticevaluationwithcontrastenhancedultrasoundcomputedtomographyandmagneticresonanceimaginginpatientswithpancreaticcysticneoplasms
AT zhoufubo comparativediagnosticevaluationwithcontrastenhancedultrasoundcomputedtomographyandmagneticresonanceimaginginpatientswithpancreaticcysticneoplasms
AT luyuhan comparativediagnosticevaluationwithcontrastenhancedultrasoundcomputedtomographyandmagneticresonanceimaginginpatientswithpancreaticcysticneoplasms
AT liangping comparativediagnosticevaluationwithcontrastenhancedultrasoundcomputedtomographyandmagneticresonanceimaginginpatientswithpancreaticcysticneoplasms
AT yehuiyi comparativediagnosticevaluationwithcontrastenhancedultrasoundcomputedtomographyandmagneticresonanceimaginginpatientswithpancreaticcysticneoplasms
AT yuxiaoling comparativediagnosticevaluationwithcontrastenhancedultrasoundcomputedtomographyandmagneticresonanceimaginginpatientswithpancreaticcysticneoplasms